Denali Therapeutics Ownership 2024 | Who Owns Denali Therapeutics Now?

Overview Forecast RevenueFinancials Chart

Institutional Ownership

39.24%

Insider Ownership

13.71%

Retail Ownership

47.04%

Institutional Holders

108.00

Denali Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BAILLIE GIFFORD & CO	10.22%	0.22%	14,041,228	-219,496	-1.54%	288,125,999	Mar 31, 2024
BLACKROCK INC.	8.88%	0.01%	12,199,856	656,410	5.69%	250,341,043	Mar 31, 2024
VANGUARD GROUP INC	7.98%	0.00%	10,968,293	133,810	1.24%	225,069,372	Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP	6.02%	0.03%	8,269,949	995,232	13.68%	169,699,354	Mar 31, 2024
STATE STREET CORP	4.60%	0.01%	6,323,872	837,924	15.27%	129,765,853	Mar 31, 2024
CAPITAL RESEARCH GLOBAL INVESTORS	4.40%	0.03%	6,049,957	3,140,429	107.94%	124,145,118	Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD	4.15%	0.65%	5,706,345	-1,189,647	-17.25%	117,094,199	Mar 31, 2024
CRESTLINE MANAGEMENT, LP	3.79%	9.45%	5,210,732	-450,000	-7.95%	106,924,221	Mar 31, 2024
BAKER BROS. ADVISORS LP	2.72%	0.96%	3,731,695	1,124,499	43.13%	76,574,381	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	2.01%	0.01%	2,759,633	100,337	3.77%	56,636,392	Mar 31, 2024
MARSHALL WACE, LLP	1.56%	0.07%	2,146,379	478,982	28.73%	44,043,696	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	1.29%	0.01%	1,777,907	-92,720	-4.96%	36,482,644	Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/	1.16%	0.00%	1,594,333	-979,988	-38.07%	32,716,000	Mar 31, 2024
CREDIT SUISSE AG/	1.14%	0.03%	1,566,246	-9,975	-0.63%	32,139,369	Mar 31, 2024
CAMBER CAPITAL MANAGEMENT LP	1.09%	0.75%	1,500,000	1,500,000	100.00%	30,780,000	Mar 31, 2024
CITADEL ADVISORS LLC	0.99%	0.01%	1,365,028	1,296,918	1904.15%	28,010,374	Mar 31, 2024
FLAGSHIP PIONEERING INC.	0.99%	1.84%	1,364,516	-955,452	-41.18%	27,999,868	Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP	0.97%	0.01%	1,332,950	213,322	19.05%	27,352,134	Mar 31, 2024
CASDIN CAPITAL, LLC	0.95%	1.98%	1,300,000	-	-	26,676,000	Mar 31, 2024
FMR LLC	0.90%	0.00%	1,232,522	590,869	92.09%	25,291,348	Mar 31, 2024

Denali Therapeutics's largest institutional shareholder is BAILLIE GIFFORD & CO, holding 10.22% of the company's total share outstanding, currently valued at $288.13M. The top 10 institutional shareholders own together 54.79% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARCH VENTURE MANAGEMENT, LLC	0.28%	9.75%	381,249	-	-	7,823,229	Mar 31, 2024
CRESTLINE MANAGEMENT, LP	3.79%	9.45%	5,210,732	-450,000	-7.95%	106,924,221	Mar 31, 2024
CASDIN CAPITAL, LLC	0.95%	1.98%	1,300,000	-	-	26,676,000	Mar 31, 2024
ALTITUDE CREST PARTNERS INC.	0.15%	1.84%	209,613	209,613	100.00%	4,301,259	Mar 31, 2024
FLAGSHIP PIONEERING INC.	0.99%	1.84%	1,364,516	-955,452	-41.18%	27,999,868	Mar 31, 2024
YIHENG CAPITAL MANAGEMENT, L.P.	0.84%	1.31%	1,150,684	-	-	23,612,036	Mar 31, 2024
BAKER BROS. ADVISORS LP	2.72%	0.96%	3,731,695	1,124,499	43.13%	76,574,381	Mar 31, 2024
CAMBER CAPITAL MANAGEMENT LP	1.09%	0.75%	1,500,000	1,500,000	100.00%	30,780,000	Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD	4.15%	0.65%	5,706,345	-1,189,647	-17.25%	117,094,199	Mar 31, 2024
CLARIUS GROUP, LLC	0.29%	0.56%	392,218	13,956	3.69%	8,048,313	Mar 31, 2024
PIER CAPITAL, LLC	0.13%	0.49%	172,331	-1,888	-1.08%	3,536,232	Mar 31, 2024
IRONWOOD INVESTMENT MANAGEMENT LLC	0.03%	0.36%	36,064	18,126	101.05%	740,033	Mar 31, 2024
CERCANO MANAGEMENT LLC	0.46%	0.36%	625,000	-	-	12,825,000	Mar 31, 2024
PDT PARTNERS, LLC	0.12%	0.31%	158,384	125,484	381.41%	3,250,040	Mar 31, 2024
GILDER GAGNON HOWE & CO LLC	0.85%	0.30%	1,172,785	-46,607	-3.82%	24,065,558	Mar 31, 2024
ARTAL GROUP S.A.	0.37%	0.26%	502,899	-300,000	-37.36%	10,319,487	Mar 31, 2024
HARVEST INVESTMENT SERVICES, LLC	0.02%	0.23%	27,978	27,978	100.00%	574,108	Mar 31, 2024
BAILLIE GIFFORD & CO	10.22%	0.22%	14,041,228	-219,496	-1.54%	288,125,999	Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	0.15%	0.20%	211,017	211,017	100.00%	4,330,069	Mar 31, 2024
PIER 88 INVESTMENT PARTNERS LLC	0.03%	0.20%	39,970	-5,270	-11.65%	820,184	Mar 31, 2024

The largest Denali Therapeutics shareholder by % of total assets is ARCH VENTURE MANAGEMENT, LLC. The company owns 381.25K shares of Denali Therapeutics (DNLI), representing 9.75% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CAPITAL RESEARCH GLOBAL INVESTORS	4.40%	0.03%	6,049,957	3,140,429	107.94%	124,145,118	Mar 31, 2024
CAMBER CAPITAL MANAGEMENT LP	1.09%	0.75%	1,500,000	1,500,000	100.00%	30,780,000	Mar 31, 2024
CITADEL ADVISORS LLC	0.99%	0.01%	1,365,028	1,296,918	1904.15%	28,010,374	Mar 31, 2024
BAKER BROS. ADVISORS LP	2.72%	0.96%	3,731,695	1,124,499	43.13%	76,574,381	Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP	6.02%	0.03%	8,269,949	995,232	13.68%	169,699,354	Mar 31, 2024
HOLOCENE ADVISORS, LP	0.63%	0.06%	860,948	860,948	100.00%	17,666,653	Mar 31, 2024
STATE STREET CORP	4.60%	0.01%	6,323,872	837,924	15.27%	129,765,853	Mar 31, 2024
BLACKROCK INC.	8.88%	0.01%	12,199,856	656,410	5.69%	250,341,043	Mar 31, 2024
FMR LLC	0.90%	0.00%	1,232,522	590,869	92.09%	25,291,348	Mar 31, 2024
GOLDMAN SACHS GROUP INC	0.66%	0.00%	904,361	510,556	129.65%	18,557,488	Mar 31, 2024
MARSHALL WACE, LLP	1.56%	0.07%	2,146,379	478,982	28.73%	44,043,696	Mar 31, 2024
FISHER ASSET MANAGEMENT, LLC	0.34%	0.00%	469,169	466,436	17066.81%	9,627,347	Mar 31, 2024
BANK OF AMERICA CORP /DE/	0.62%	0.00%	851,976	393,338	85.76%	17,482,547,000	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	0.28%	0.00%	390,616	390,616	100.00%	8,015,440	Mar 31, 2024
WOODLINE PARTNERS LP	0.37%	0.10%	508,565	310,981	157.39%	10,435,754	Mar 31, 2024
CITIGROUP INC	0.28%	0.01%	382,416	241,140	170.69%	7,847,176	Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP	0.97%	0.01%	1,332,950	213,322	19.05%	27,352,134	Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	0.15%	0.20%	211,017	211,017	100.00%	4,330,069	Mar 31, 2024
ALTITUDE CREST PARTNERS INC.	0.15%	1.84%	209,613	209,613	100.00%	4,301,259	Mar 31, 2024
ABRDN PLC	0.38%	0.02%	516,019	191,190	58.86%	10,588,710	Mar 31, 2024

As of Mar 31 2024, Denali Therapeutics's largest institutional buyer is CAPITAL RESEARCH GLOBAL INVESTORS. The company purchased 3.14M stocks of DNLI, valued at $124.15M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FEDERATED HERMES, INC.	-	-	-	-1,351,900	-100.00%	-	Mar 31, 2024
TEMASEK HOLDINGS (PRIVATE) LTD	4.15%	0.65%	5,706,345	-1,189,647	-17.25%	117,094,199	Mar 31, 2024
PRICE T ROWE ASSOCIATES INC /MD/	1.16%	0.00%	1,594,333	-979,988	-38.07%	32,716,000	Mar 31, 2024
FLAGSHIP PIONEERING INC.	0.99%	1.84%	1,364,516	-955,452	-41.18%	27,999,868	Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.	-	-	-	-644,406	-100.00%	-	Mar 31, 2024
BRAIDWELL LP	-	-	-	-461,769	-100.00%	-	Mar 31, 2024
CRESTLINE MANAGEMENT, LP	3.79%	9.45%	5,210,732	-450,000	-7.95%	106,924,221	Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA	0.01%	0.00%	13,796	-425,422	-96.86%	283,094	Mar 31, 2024
EAGLE ASSET MANAGEMENT INC	-	-	-	-315,520	-100.00%	-	Mar 31, 2024
SKANDINAVISKA ENSKILDA BANKEN AB (PUBL)	0.03%	0.00%	43,245	-304,958	-87.58%	887,387	Mar 31, 2024
ARTAL GROUP S.A.	0.37%	0.26%	502,899	-300,000	-37.36%	10,319,487	Mar 31, 2024
MITSUBISHI UFJ TRUST & BANKING CORP	-	-	-	-246,190	-100.00%	-	Mar 31, 2024
BAILLIE GIFFORD & CO	10.22%	0.22%	14,041,228	-219,496	-1.54%	288,125,999	Mar 31, 2024
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	-	-	-	-176,131	-100.00%	-	Mar 31, 2024
BARCLAYS PLC	0.11%	0.00%	151,560	-172,459	-53.23%	3,110,000	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-161,946	-100.00%	-	Mar 31, 2024
SCHRODER INVESTMENT MANAGEMENT GROUP	-	-	-	-154,000	-100.00%	-	Mar 31, 2024
NEUBERGER BERMAN GROUP LLC	-	-	-	-144,461	-100.00%	-	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	0.03%	0.00%	37,749	-133,513	-77.96%	774,609	Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC	0.05%	0.00%	72,105	-119,538	-62.38%	1,479,595	Mar 31, 2024

As of Mar 31 2024, Denali Therapeutics's biggest institutional seller is FEDERATED HERMES, INC.. The company sold -1.35M shares of DNLI, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CAMBER CAPITAL MANAGEMENT LP	1.09%	0.75%	1,500,000	1,500,000	100.00%	30,780,000	Mar 31, 2024
HOLOCENE ADVISORS, LP	0.63%	0.06%	860,948	860,948	100.00%	17,666,653	Mar 31, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	0.15%	0.20%	211,017	211,017	100.00%	4,330,069	Mar 31, 2024
ALTITUDE CREST PARTNERS INC.	0.15%	1.84%	209,613	209,613	100.00%	4,301,259	Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC	0.09%	0.01%	127,270	127,270	100.00%	2,611,580	Mar 31, 2024
D. E. SHAW & CO., INC.	0.08%	0.00%	116,265	116,265	100.00%	2,385,758	Mar 31, 2024
EDGESTREAM PARTNERS, L.P.	0.08%	0.11%	112,118	112,118	100.00%	2,300,661	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.08%	0.00%	104,640	104,640	100.00%	2,147,213	Mar 31, 2024
ALGERT GLOBAL LLC	0.06%	0.07%	82,000	82,000	100.00%	1,683,000	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.05%	0.00%	69,800	69,800	100.00%	1,432,296	Mar 31, 2024
PEAK6 INVESTMENTS LLC	0.04%	0.00%	54,600	54,600	100.00%	1,120,392	Mar 31, 2024
UBS OCONNOR LLC	0.04%	0.00%	50,000	50,000	100.00%	30,000	Mar 31, 2024
BANK OF MONTREAL /CAN/	0.03%	0.00%	42,288	42,288	100.00%	881,282	Mar 31, 2024
EP WEALTH ADVISORS, LLC	0.03%	0.01%	40,500	40,500	100.00%	831,060	Mar 31, 2024
EISLER CAPITAL (US) LLC	0.03%	0.02%	34,480	34,480	100.00%	707,530	Mar 31, 2024
LPL FINANCIAL LLC	0.02%	0.00%	34,085	34,085	100.00%	699,424	Mar 31, 2024
HARVEST INVESTMENT SERVICES, LLC	0.02%	0.23%	27,978	27,978	100.00%	574,108	Mar 31, 2024
TWO SIGMA ADVISERS, LP	0.02%	0.00%	21,900	21,900	100.00%	449,388	Mar 31, 2024
NEOS INVESTMENT MANAGEMENT LLC	0.02%	0.03%	21,648	21,648	100.00%	444,217	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.01%	0.00%	18,400	18,400	100.00%	377,568	Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC	0.01%	0.00%	11,001	11,001	100.00%	225,741	Mar 31, 2024
MACKENZIE FINANCIAL CORP	0.01%	0.00%	10,560	10,560	100.00%	216,691	Mar 31, 2024
PEAK6 INVESTMENTS LLC	0.01%	0.00%	10,000	10,000	100.00%	205,200	Mar 31, 2024
GROUP ONE TRADING, L.P.	0.01%	0.00%	8,455	8,455	100.00%	173,497	Mar 31, 2024
QUARRY LP	0.01%	0.03%	7,000	7,000	100.00%	143,640	Mar 31, 2024
FERNWOOD INVESTMENT MANAGEMENT, LLC	0.00%	0.03%	5,000	5,000	100.00%	102,600,000	Mar 31, 2024
SIMPLEX TRADING, LLC	0.00%	0.00%	4,928	4,928	100.00%	101,000	Mar 31, 2024
HEADLANDS TECHNOLOGIES LLC	0.00%	0.02%	4,295	4,295	100.00%	88,133	Mar 31, 2024
PACER ADVISORS, INC.	0.00%	0.00%	2,025	2,025	100.00%	41,553	Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC	0.00%	0.01%	2,000	2,000	100.00%	41,040	Mar 31, 2024
	0.00%	0.02%	784	784	100.00%	16,088	Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC	0.00%	0.00%	153	153	100.00%	3,139	Mar 31, 2024
FINANCIAL SYNERGIES WEALTH ADVISORS, INC.	-	0.00%	36	36	100.00%	739,000	Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC	-	-	1	1	100.00%	21,000	Mar 31, 2024

Denali Therapeutics's largest new institutional shareholder by number of shares is CAMBER CAPITAL MANAGEMENT LP, purchased 1.50M shares, valued at $30.78M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FEDERATED HERMES, INC.	-	-	-	-1,351,900	-100.00%	-	Mar 31, 2024
POINT72 ASSET MANAGEMENT, L.P.	-	-	-	-644,406	-100.00%	-	Mar 31, 2024
BRAIDWELL LP	-	-	-	-461,769	-100.00%	-	Mar 31, 2024
EAGLE ASSET MANAGEMENT INC	-	-	-	-315,520	-100.00%	-	Mar 31, 2024
MITSUBISHI UFJ TRUST & BANKING CORP	-	-	-	-246,190	-100.00%	-	Mar 31, 2024
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	-	-	-	-176,131	-100.00%	-	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	-	-	-	-161,946	-100.00%	-	Mar 31, 2024
SCHRODER INVESTMENT MANAGEMENT GROUP	-	-	-	-154,000	-100.00%	-	Mar 31, 2024
NEUBERGER BERMAN GROUP LLC	-	-	-	-144,461	-100.00%	-	Mar 31, 2024
PATHWAY CAPITAL MANAGEMENT, LP	-	-	-	-69,450	-100.00%	-	Mar 31, 2024
CAMPBELL & CO INVESTMENT ADVISER LLC	-	-	-	-65,105	-100.00%	-	Mar 31, 2024
HARBOR CAPITAL ADVISORS, INC.	-	-	-	-60,304	-100.00%	-	Mar 31, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	-	-	-	-46,000	-100.00%	-	Mar 31, 2024
HRT FINANCIAL LP	-	-	-	-44,292	-100.00%	-	Mar 31, 2024
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO	-	-	-	-30,428	-100.00%	-	Mar 31, 2024
CAPTION MANAGEMENT, LLC	-	-	-	-30,000	-100.00%	-	Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD	-	-	-	-27,429	-100.00%	-	Mar 31, 2024
VELA INVESTMENT MANAGEMENT, LLC	-	-	-	-26,145	-100.00%	-	Mar 31, 2024
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	-	-	-	-24,318	-100.00%	-	Mar 31, 2024
LEVIN CAPITAL STRATEGIES, L.P.	-	-	-	-24,000	-100.00%	-	Mar 31, 2024
BARCLAYS PLC	-	-	-	-22,500	-100.00%	-	Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC	-	-	-	-18,327	-100.00%	-	Mar 31, 2024
ARTHUR M. COHEN & ASSOCIATES, LLC	-	-	-	-10,564	-100.00%	-	Mar 31, 2024
QUEST PARTNERS LLC	-	-	-	-9,965	-100.00%	-	Mar 31, 2024
BRANDYWINE MANAGERS, LLC	-	-	-	-9,601	-100.00%	-	Mar 31, 2024
AQUATIC CAPITAL MANAGEMENT LLC	-	-	-	-8,300	-100.00%	-	Mar 31, 2024
TAO CAPITAL MANAGEMENT LP	-	-	-	-3,042	-100.00%	-	Mar 31, 2024
WALLEYE CAPITAL LLC	-	-	-	-1,600	-100.00%	-	Mar 31, 2024
ADVISORY SERVICES NETWORK, LLC	-	-	-	-309	-100.00%	-	Mar 31, 2024
MORTON BROWN FAMILY WEALTH, LLC	-	-	-	-298	-100.00%	-	Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC	-	-	-	-77	-100.00%	-	Mar 31, 2024
GLASSMAN WEALTH SERVICES	-	-	-	-29	-100.00%	-	Mar 31, 2024
QUADRANT CAPITAL GROUP LLC	-	-	-	-19	-100.00%	-	Mar 31, 2024
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC	-	-	-	-11	-100.00%	-	Mar 31, 2024

Denali Therapeutics's largest sold out institutional shareholder by shares sold is FEDERATED HERMES, INC., sold -1.35M shares, valued at -, as of undefined.

Denali Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BNY MELLON VARIABLE INVESTMENT FUND	0.76%	183,992	17,800	10.71%	Mar 31, 2024
HARTFORD HLS SERIES FUND II INC	0.52%	128,223	-	-	Dec 31, 2023
Tema ETF Trust	0.48%	21,648	21,648	-	Feb 29, 2024
HSBC FUNDS	0.44%	14,320	-	-	Jan 31, 2024
NEW ECONOMY FUND	0.25%	1,141,800	1,141,800	-	Feb 29, 2024
TEKLA LIFE SCIENCES INVESTORS	0.19%	110,331	-	-	Dec 31, 2023
TEKLA HEALTHCARE INVESTORS	0.19%	214,498	-	-	Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS	0.15%	72,022	-	-	Dec 31, 2023
T. Rowe Price Health Sciences Fund, Inc.	0.10%	517,185	-260,396	-33.49%	Dec 31, 2023
VANGUARD SPECIALIZED FUNDS	0.09%	5,100,454	-	-	Jan 31, 2024
T. Rowe Price New Horizons Fund, Inc.	0.08%	1,197,891	-3,830	-0.32%	Dec 31, 2023
ALGER FUNDS	0.08%	74,209	-	-	Jan 31, 2024
PRUDENTIAL SECTOR FUNDS, INC.	0.08%	159,975	-	-	Feb 29, 2024
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.	0.08%	41,150	-	-	Dec 31, 2023
VELA Funds	0.08%	25,358	5,887	30.23%	Dec 31, 2023
Humankind Benefit Corp	0.07%	1,578	270	20.64%	Dec 31, 2023
T. Rowe Price Quantitative Management Funds, Inc.	0.07%	257,800	-34,700	-11.86%	Dec 31, 2023
Voya VARIABLE PRODUCTS TRUST	0.07%	19,824	242	1.24%	Dec 31, 2023
Voya EQUITY TRUST	0.05%	77,684	8,227	11.84%	Feb 29, 2024
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)	0.05%	350,000	-	-	Dec 31, 2023
CORNERCAP GROUP OF FUNDS /VA/	0.04%	3,241	-	-	Sep 30, 2022
AMG FUNDS III	0.04%	7,155	-	-	Feb 29, 2024
WASATCH FUNDS TRUST	0.04%	380,297	82,184	27.57%	Mar 31, 2024
BlackRock Health Sciences Trust II	0.04%	111,300	-	-	Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.04%	17,957	171	0.96%	Dec 31, 2023
T. Rowe Price Small-Cap Value Fund, Inc.	0.04%	289,938	-149,200	-33.98%	Dec 31, 2023
SMALLCAP WORLD FUND INC	0.04%	2,512,759	29,205	1.18%	Dec 31, 2023
Federated Hermes MDT Series	0.04%	87,096	-	-	Jan 31, 2024
FIDELITY ADVISOR SERIES VII	0.03%	281,664	-	-	Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC	0.03%	215,122	14,782	7.38%	Dec 31, 2023
BlackRock Advantage SMID Cap Fund, Inc.	0.03%	5,386	-2,826	-34.41%	Dec 29, 2023
T. Rowe Price Tax-Efficient Funds, Inc.	0.03%	2,500	-	-	Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND IV	0.03%	70,000	-	-	Dec 31, 2023
PRUDENTIAL JENNISON BLEND FUND, INC.	0.03%	16,396	-	-	Feb 29, 2024
VANGUARD INDEX FUNDS	0.02%	11,027,660	1,940,537	21.35%	Dec 31, 2023
VANGUARD EXPLORER FUND	0.02%	200,354	-	-	Jan 31, 2024
Calvert Responsible Index Series, Inc.	0.02%	25,982	-	-	Dec 31, 2023
VANGUARD WORLD FUND	0.02%	3,910,667	-137,179	-3.39%	Feb 29, 2024
Vericimetry Funds	0.02%	1,600	-	-	Dec 31, 2023
Northern Lights Variable Trust	0.01%	14,684	-	-	Dec 31, 2023
T. Rowe Price Equity Series, Inc.	0.01%	24,383	-11,488	-32.03%	Dec 31, 2023
Harbor ETF Trust	0.01%	60,469	7,901	15.03%	Jan 31, 2024
TIAA SEPARATE ACCOUNT VA 1	0.01%	2,697	-	-	Dec 31, 2023
BARON SELECT FUNDS	0.01%	129,200	-	-	Dec 31, 2023
FIDELITY COMMONWEALTH TRUST	0.01%	34,831	558	1.63%	Feb 29, 2024
BNY Mellon Strategic Funds, Inc.	0.01%	22,761	-	-	Mar 31, 2024
ALPS ETF Trust	0.01%	105,734	8,662	8.92%	Feb 29, 2024
JNL VARIABLE FUND LLC	0.01%	43,646	-5,376	-10.97%	Mar 31, 2020
Fidelity Central Investment Portfolios LLC	0.01%	140,000	-	-	Feb 29, 2024
Nushares ETF Trust	0.01%	47,340	-	-	Jan 31, 2024
PROFESSIONALLY MANAGED PORTFOLIOS	0.01%	36,364	-	-	Feb 29, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.	0.01%	15,391	-	-	Dec 31, 2023
FIDELITY CONCORD STREET TRUST	0.01%	1,140,343	-5,024	-0.44%	Feb 29, 2024
Calvert Variable Products, Inc.	0.00%	12,230	492	4.19%	Dec 31, 2023
LORD ABBETT SECURITIES TRUST	0.00%	22,119	-	-	Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND	0.00%	16,132	-	-	Jan 31, 2024
Bernstein Fund Inc	0.00%	41,960	-	-	Dec 31, 2023
ProFunds	0.00%	35,938	16,896	88.73%	Jan 31, 2024
SCHWAB STRATEGIC TRUST	0.00%	653,477	26,552	4.24%	Feb 29, 2024
SunAmerica Specialty Series	0.00%	1,791	-145	-7.49%	Apr 30, 2021
FIDELITY SELECT PORTFOLIOS	0.00%	200,069	-88,900	-30.76%	Feb 29, 2024
BAILLIE GIFFORD FUNDS	0.00%	30,985	-6,207	-16.69%	Dec 29, 2023
Fidelity Commonwealth Trust II	0.00%	18,724	-	-	Aug 31, 2023
ETFis Series Trust I	0.00%	3,540	495	16.26%	Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	68,961	-	-	Dec 31, 2023
FEDERATED HERMES INSURANCE SERIES	0.00%	10,400	-	-	Dec 31, 2023
BNY MELLON FUNDS TRUST	0.00%	158,149	158,149	-	Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND	0.00%	37,500	-	-	Dec 31, 2023
Direxion Shares ETF Trust	0.00%	309,131	129,022	71.64%	Jan 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST	0.00%	6,528	-	-	Dec 31, 2023
PFM Multi-Manager Series Trust	0.00%	1,300	-	-	Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC	0.00%	47,297	241	0.51%	Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II	0.00%	18,234	-2,290	-11.16%	Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC	0.00%	5,840	-277	-4.53%	Dec 31, 2023
Principal Exchange-Traded Funds	0.00%	15,561	-1,280	-7.60%	Mar 31, 2024
T. Rowe Price Index Trust, Inc.	0.00%	21,892	-	-	Feb 29, 2024
AMG Funds IV	0.00%	3,561	-	-	Jan 31, 2024
Advisors' Inner Circle Fund III	0.00%	17,381	322	1.89%	Jan 31, 2024
FIDELITY COVINGTON TRUST	0.00%	15,623	-1	-0.01%	Feb 29, 2024
FIDELITY CONTRAFUND	0.00%	71,928	-	-	Dec 31, 2023
PRINCIPAL VARIABLE CONTRACTS FUNDS INC	0.00%	41,100	13,200	47.31%	Dec 31, 2023
LORD ABBETT SERIES FUND INC	0.00%	22,260	-	-	Dec 31, 2023
OHIO NATIONAL FUND INC	0.00%	19,493	-	-	Dec 31, 2023
TIMOTHY PLAN	0.00%	4,295	-	-	Mar 31, 2024
NORTHWESTERN MUTUAL SERIES FUND INC	0.00%	113,301	-	-	Dec 31, 2023
STEWARD FUNDS, INC.	0.00%	2,180	-	-	Jan 31, 2024
SSGA FUNDS	0.00%	377	-	-	Feb 29, 2024
Dimensional ETF Trust	0.00%	377,917	15,263	4.21%	Jan 31, 2024
TIAA-CREF LIFE FUNDS	0.00%	1,799	-	-	Dec 31, 2023
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.	0.00%	5,900	-1,500	-20.27%	Dec 29, 2023
NEW COVENANT FUNDS	0.00%	2,631	-	-	Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	608,006	142,506	30.61%	Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	42,236	3,404	8.77%	Dec 31, 2023
VANGUARD HORIZON FUNDS	0.00%	9,921	-	-	Dec 31, 2023
HARTFORD MUTUAL FUNDS II INC	0.00%	68,926	-6,125	-8.16%	Jan 31, 2024
JOHN HANCOCK INVESTMENT TRUST	0.00%	35,031	21,765	164.07%	Jan 31, 2024
MASTER INVESTMENT PORTFOLIO	0.00%	35,215	14,159	67.24%	Dec 31, 2023
Janus Detroit Street Trust	0.00%	60,189	-	-	Jan 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST	0.00%	26,298	24	0.09%	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	331,801	-5,506	-1.63%	Dec 31, 2023

Denali Therapeutics's largest mutual fund holder by % of total assets is "BNY MELLON VARIABLE INVESTMENT FUND", owning 183.99K shares, compromising 0.76% of its total assets.

Denali Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	108	-49.77%
31 Dec, 23	215	10.26%
30 Sep, 23	195	-0.51%
30 Jun, 23	196	-1.01%
31 Mar, 23	198	0.51%
31 Dec, 22	197	1.03%
30 Sep, 22	195	9.55%
30 Jun, 22	178	-0.56%
31 Mar, 22	179	-13.94%
31 Dec, 21	208	-1.89%
30 Sep, 21	212	-
30 Jun, 21	212	-4.07%
31 Mar, 21	221	5.74%
31 Dec, 20	209	22.22%
30 Sep, 20	171	21.28%
30 Jun, 20	141	10.16%
31 Mar, 20	128	18.52%
31 Dec, 19	108	-5.26%
30 Sep, 19	114	2.70%
30 Jun, 19	111	-1.77%
31 Mar, 19	113	26.97%
31 Dec, 18	89	14.10%
30 Sep, 18	78	16.42%
30 Jun, 18	67	15.52%
31 Mar, 18	58	28.89%
31 Dec, 17	45	-

As of 31 Mar 24, 108 institutions are holding Denali Therapeutics's shares, representing a decrease of -49.77% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	53,910,296	-51.28%
31 Dec, 23	110,657,500	2.78%
30 Sep, 23	107,663,172	0.58%
30 Jun, 23	107,046,214	0.51%
31 Mar, 23	106,499,159	0.73%
31 Dec, 22	105,722,741	14.64%
30 Sep, 22	92,222,269	-0.38%
30 Jun, 22	92,572,550	6.92%
31 Mar, 22	86,577,557	1.75%
31 Dec, 21	85,090,357	0.26%
30 Sep, 21	84,869,735	5.32%
30 Jun, 21	80,584,019	0.17%
31 Mar, 21	80,445,506	-9.19%
31 Dec, 20	88,583,074	7.24%
30 Sep, 20	82,605,122	-0.01%
30 Jun, 20	82,614,227	2.90%
31 Mar, 20	80,286,511	13.53%
31 Dec, 19	70,718,121	-0.76%
30 Sep, 19	71,256,758	-0.16%
30 Jun, 19	71,368,628	3.40%
31 Mar, 19	69,021,005	1.36%
31 Dec, 18	68,095,251	1.68%
30 Sep, 18	66,971,885	7.66%
30 Jun, 18	62,206,524	1.84%
31 Mar, 18	61,082,898	5.05%
31 Dec, 17	58,144,610	-

Denali Therapeutics (DNLI) has 53.91M shares outstanding as of 31 Mar 24, down -51.28% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	39.24%	0.61%
31 Dec, 23	80.39%	1.30%
30 Sep, 23	78.56%	1.28%
30 Jun, 23	78.41%	1.29%
31 Mar, 23	78.01%	1.23%
31 Dec, 22	79.56%	1.43%
30 Sep, 22	74.69%	1.32%
30 Jun, 22	75.26%	1.51%
31 Mar, 22	70.58%	1.45%
31 Dec, 21	69.65%	1.43%
30 Sep, 21	69.71%	1.58%
30 Jun, 21	66.44%	1.50%
31 Mar, 21	66.55%	1.22%
31 Dec, 20	73.72%	1.25%
30 Sep, 20	76.85%	1.26%
30 Jun, 20	78.15%	1.27%
31 Mar, 20	78.39%	1.43%
31 Dec, 19	73.97%	1.34%
30 Sep, 19	74.33%	1.33%
30 Jun, 19	74.74%	1.42%
31 Mar, 19	72.67%	1.39%
31 Dec, 18	72.21%	1.41%
30 Sep, 18	71.50%	1.59%
30 Jun, 18	66.96%	1.44%
31 Mar, 18	68.20%	1.62%
31 Dec, 17	64.92%	-

As of 31 Mar 24, Denali Therapeutics is held by 39.24% institutional shareholders, representing a 0.61% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	57	-46.23%
31 Dec, 23	106	-
30 Sep, 23	106	-2.75%
30 Jun, 23	109	-4.39%
31 Mar, 23	114	3.64%
31 Dec, 22	110	0.92%
30 Sep, 22	109	19.78%
30 Jun, 22	91	10.98%
31 Mar, 22	82	-23.36%
31 Dec, 21	107	-6.14%
30 Sep, 21	114	-
30 Jun, 21	114	-4.20%
31 Mar, 21	119	-0.83%
31 Dec, 20	120	25.00%
30 Sep, 20	96	12.94%
30 Jun, 20	85	-2.30%
31 Mar, 20	87	93.33%
31 Dec, 19	45	-13.46%
30 Sep, 19	52	-17.46%
30 Jun, 19	63	-5.97%
31 Mar, 19	67	17.54%
31 Dec, 18	57	-
30 Sep, 18	57	23.91%
30 Jun, 18	46	9.52%
31 Mar, 18	42	-6.67%
31 Dec, 17	45	-

57 institutional shareholders have increased their position in DNLI stock as of 31 Mar 24 compared to 106 in the previous quarter (a -46.23% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	36	-47.83%
31 Dec, 23	69	21.05%
30 Sep, 23	57	11.76%
30 Jun, 23	51	4.08%
31 Mar, 23	49	-5.77%
31 Dec, 22	52	-3.70%
30 Sep, 22	54	1.89%
30 Jun, 22	53	-15.87%
31 Mar, 22	63	-
31 Dec, 21	63	-1.56%
30 Sep, 21	64	6.67%
30 Jun, 21	60	-11.76%
31 Mar, 21	68	1.49%
31 Dec, 20	67	36.73%
30 Sep, 20	49	44.12%
30 Jun, 20	34	61.90%
31 Mar, 20	21	-43.24%
31 Dec, 19	37	48.00%
30 Sep, 19	25	8.70%
30 Jun, 19	23	-11.54%
31 Mar, 19	26	23.81%
31 Dec, 18	21	90.91%
30 Sep, 18	11	-15.38%
30 Jun, 18	13	62.50%
31 Mar, 18	8	-
31 Dec, 17	-	-

36 institutional shareholders have reduced their position in DNLI stock as of 31 Mar 24 compared to 69 in the previous quarter (a -47.83% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	108	-49.77%	53,910,296	-51.28%	39.24%	0.61%	57	-46.23%	36	-47.83%
31 Dec, 23	215	10.26%	110,657,500	2.78%	80.39%	1.30%	106	-	69	21.05%
30 Sep, 23	195	-0.51%	107,663,172	0.58%	78.56%	1.28%	106	-2.75%	57	11.76%
30 Jun, 23	196	-1.01%	107,046,214	0.51%	78.41%	1.29%	109	-4.39%	51	4.08%
31 Mar, 23	198	0.51%	106,499,159	0.73%	78.01%	1.23%	114	3.64%	49	-5.77%
31 Dec, 22	197	1.03%	105,722,741	14.64%	79.56%	1.43%	110	0.92%	52	-3.70%
30 Sep, 22	195	9.55%	92,222,269	-0.38%	74.69%	1.32%	109	19.78%	54	1.89%
30 Jun, 22	178	-0.56%	92,572,550	6.92%	75.26%	1.51%	91	10.98%	53	-15.87%
31 Mar, 22	179	-13.94%	86,577,557	1.75%	70.58%	1.45%	82	-23.36%	63	-
31 Dec, 21	208	-1.89%	85,090,357	0.26%	69.65%	1.43%	107	-6.14%	63	-1.56%
30 Sep, 21	212	-	84,869,735	5.32%	69.71%	1.58%	114	-	64	6.67%
30 Jun, 21	212	-4.07%	80,584,019	0.17%	66.44%	1.50%	114	-4.20%	60	-11.76%
31 Mar, 21	221	5.74%	80,445,506	-9.19%	66.55%	1.22%	119	-0.83%	68	1.49%
31 Dec, 20	209	22.22%	88,583,074	7.24%	73.72%	1.25%	120	25.00%	67	36.73%
30 Sep, 20	171	21.28%	82,605,122	-0.01%	76.85%	1.26%	96	12.94%	49	44.12%
30 Jun, 20	141	10.16%	82,614,227	2.90%	78.15%	1.27%	85	-2.30%	34	61.90%
31 Mar, 20	128	18.52%	80,286,511	13.53%	78.39%	1.43%	87	93.33%	21	-43.24%
31 Dec, 19	108	-5.26%	70,718,121	-0.76%	73.97%	1.34%	45	-13.46%	37	48.00%
30 Sep, 19	114	2.70%	71,256,758	-0.16%	74.33%	1.33%	52	-17.46%	25	8.70%
30 Jun, 19	111	-1.77%	71,368,628	3.40%	74.74%	1.42%	63	-5.97%	23	-11.54%
31 Mar, 19	113	26.97%	69,021,005	1.36%	72.67%	1.39%	67	17.54%	26	23.81%
31 Dec, 18	89	14.10%	68,095,251	1.68%	72.21%	1.41%	57	-	21	90.91%
30 Sep, 18	78	16.42%	66,971,885	7.66%	71.50%	1.59%	57	23.91%	11	-15.38%
30 Jun, 18	67	15.52%	62,206,524	1.84%	66.96%	1.44%	46	9.52%	13	62.50%
31 Mar, 18	58	28.89%	61,082,898	5.05%	68.20%	1.62%	42	-6.67%	8	-
31 Dec, 17	45	-	58,144,610	-	64.92%	-	45	-	-	-

Denali Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 17, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,674	$20.39	$34.13K	116,369
Apr 17, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.29	$30.47K	118,043
Apr 02, 2024	Krognes Steve E.	director	-	S-Sale	Sell	92,500	$20.50	$1.90M	47,341
Mar 19, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$20.10	$33.49K	119,709
Feb 20, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.37	$30.60K	121,375
Feb 15, 2024	Krognes Steve E.	director	-	S-Sale	Sell	2,750	$17.29	$47.55K	139,841
Feb 15, 2024	Watts Ryan J.	director, officer	President and CEO	S-Sale	Sell	9,589	$17.29	$165.79K	238,067
Feb 15, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	2,784	$17.29	$48.14K	145,010
Feb 15, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	1,405	$17.79	$24.99K	143,605
Feb 15, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	2,716	$17.29	$46.96K	207,469
Feb 15, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	20,128	$17.66	$355.46K	187,341
Jan 18, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.42	$30.69K	123,041
Jan 12, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	4,668	$19.02	$88.79K	147,794
Jan 11, 2024	Watts Ryan J.	director, officer	President and CEO	S-Sale	Sell	7,818	$19.78	$154.64K	2,268,363
Jan 09, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	9,972	$19.43	$193.76K	198,777
Jan 09, 2024	Krognes Steve E.	director	-	S-Sale	Sell	3,208	$19.43	$62.33K	142,591
Jan 09, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	9,972	$19.43	$193.76K	539,307

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 17, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,674	$20.39	$34.13K	116,369
Apr 17, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.29	$30.47K	118,043
Apr 02, 2024	Krognes Steve E.	director	-	S-Sale	Sell	92,500	$20.50	$1.90M	47,341
Mar 29, 2024	Watts Ryan J.	director, officer	President and CEO	G-Gift	Sell	40,000	-	-	2,202,604
Mar 19, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$20.10	$33.49K	119,709
Feb 20, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.37	$30.60K	121,375
Feb 15, 2024	Krognes Steve E.	director	-	S-Sale	Sell	2,750	$17.29	$47.55K	139,841
Feb 15, 2024	Watts Ryan J.	director, officer	President and CEO	S-Sale	Sell	9,589	$17.29	$165.79K	238,067
Feb 15, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	2,784	$17.29	$48.14K	145,010
Feb 15, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	1,405	$17.79	$24.99K	143,605
Feb 15, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	2,716	$17.29	$46.96K	207,469
Feb 15, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	20,128	$17.66	$355.46K	187,341
Feb 12, 2024	Schuth Alexander O.	officer	COFO and Secretary	M-Exempt	Sell	50,000	$0.68	$34.00K	145,078
Jan 18, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.42	$30.69K	123,041
Jan 12, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	4,668	$19.02	$88.79K	147,794
Jan 11, 2024	Watts Ryan J.	director, officer	President and CEO	S-Sale	Sell	7,818	$19.78	$154.64K	2,268,363
Jan 09, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	9,972	$19.43	$193.76K	198,777
Jan 09, 2024	Krognes Steve E.	director	-	S-Sale	Sell	3,208	$19.43	$62.33K	142,591
Jan 09, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	9,972	$19.43	$193.76K	539,307

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 17, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,674	$20.39	$34.13K	116,369
Apr 17, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.29	$30.47K	118,043
Apr 02, 2024	Krognes Steve E.	director	-	S-Sale	Sell	92,500	$20.50	$1.90M	47,341
Mar 29, 2024	Watts Ryan J.	director, officer	President and CEO	G-Gift	Sell	40,000	-	-	2,202,604
Mar 19, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$20.10	$33.49K	119,709
Feb 20, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.37	$30.60K	121,375
Feb 15, 2024	Krognes Steve E.	director	-	S-Sale	Sell	2,750	$17.29	$47.55K	139,841
Feb 15, 2024	Watts Ryan J.	director, officer	President and CEO	S-Sale	Sell	9,589	$17.29	$165.79K	238,067
Feb 15, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	2,784	$17.29	$48.14K	145,010
Feb 15, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	1,405	$17.79	$24.99K	143,605
Feb 15, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	2,716	$17.29	$46.96K	207,469
Feb 15, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	20,128	$17.66	$355.46K	187,341
Feb 12, 2024	Schuth Alexander O.	officer	COFO and Secretary	M-Exempt	Buy	50,000	$0.68	$34.00K	210,185
Feb 12, 2024	Schuth Alexander O.	officer	COFO and Secretary	M-Exempt	Sell	50,000	$0.68	$34.00K	145,078
Jan 18, 2024	SATO VICKI L	director	-	S-Sale	Sell	1,666	$18.42	$30.69K	123,041
Jan 12, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	4,668	$19.02	$88.79K	147,794
Jan 11, 2024	Watts Ryan J.	director, officer	President and CEO	S-Sale	Sell	7,818	$19.78	$154.64K	2,268,363
Jan 09, 2024	Ho Carole	officer	Chief Medical Officer	S-Sale	Sell	9,972	$19.43	$193.76K	198,777
Jan 09, 2024	Krognes Steve E.	director	-	S-Sale	Sell	3,208	$19.43	$62.33K	142,591
Jan 09, 2024	Schuth Alexander O.	officer	COFO and Secretary	S-Sale	Sell	9,972	$19.43	$193.76K	539,307

The last insider sell of Denali Therapeutics's stock was made by SATO VICKI L on May 17 2024, selling 1,674 shares at $20.39 per share (valued at $34.13K).

Denali Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	3	-
Q1 2024	7	17	41.18%
Q4 2023	-	3	-
Q3 2023	2	19	10.53%
Q2 2023	26	14	185.71%
Q1 2023	10	28	35.71%
Q4 2022	1	4	25.00%
Q3 2022	3	12	25.00%
Q2 2022	17	3	566.67%
Q1 2022	13	17	76.47%
Q4 2021	1	31	3.23%
Q3 2021	1	33	3.03%
Q2 2021	26	45	57.78%
Q1 2021	16	112	14.29%
Q4 2020	2	15	13.33%
Q3 2020	8	9	88.89%
Q2 2020	16	15	106.67%
Q1 2020	13	10	130.00%
Q4 2019	3	17	17.65%
Q3 2019	6	21	28.57%

0 total buy trades, and 3 total sell trades (buy/sell ratio of 0.00%) were made by Denali Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q2 2024	-	3	-
Q1 2024	-	15	-
Q4 2023	-	3	-
Q3 2023	-	17	-
Q2 2023	-	8	-
Q1 2023	-	24	-
Q4 2022	-	3	-
Q3 2022	-	10	-
Q2 2022	-	-	-
Q1 2022	-	15	-
Q4 2021	-	30	-
Q3 2021	-	32	-
Q2 2021	-	35	-
Q1 2021	-	105	-
Q4 2020	-	11	-
Q3 2020	-	2	-
Q2 2020	-	14	-
Q1 2020	-	5	-
Q4 2019	-	14	-
Q3 2019	-	11	-

As of Q2 2024, Insider owners conducted 0 open market buy trades and 3 open market sell trades of Denali Therapeutics's stocks.

Denali Therapeutics Peer Ownership

Ticker	Company
SWTX	SpringWorks Therapeutics, Inc.
DSGN	Design Therapeutics, Inc.
AKRO	Akero Therapeutics, Inc.
CERE	Cerevel Therapeutics Holdings, Inc.
TVTX	Travere Therapeutics, Inc.
BGNE	BeiGene, Ltd.
FDMT	4D Molecular Therapeutics, Inc.
PCVX	Vaxcyte, Inc.
STOK	Stoke Therapeutics, Inc.
BDTX	Black Diamond Therapeutics, Inc.
HOWL	Werewolf Therapeutics, Inc.
DAWN	Day One Biopharmaceuticals, Inc.
BCEL	Atreca, Inc.
RVMD	Revolution Medicines, Inc. Warrant
LEGN	Legend Biotech Corporation
GLUE	Monte Rosa Therapeutics, Inc.
BPMC	Blueprint Medicines Corporation
IKNA	Ikena Oncology, Inc.
APLS	Apellis Pharmaceuticals, Inc.
ASND	Ascendis Pharma A/S
FIXX	Q32 Bio Inc.
RNA	Avidity Biosciences, Inc.

DNLI Ownership FAQ

Who Owns Denali Therapeutics?

Denali Therapeutics is owned by institutional shareholders (39.24%), insiders (13.71%), and public (47.04%). The largest institutional shareholder of Denali Therapeutics is BAILLIE GIFFORD & CO (10.22% of total shares) and the top mutual fund owner is BNY MELLON VARIABLE INVESTMENT FUND (0.76% of total shares).

Who are the major institutional shareholders of Denali Therapeutics?

Denali Therapeutics's major institutional shareholders are BAILLIE GIFFORD & CO, BLACKROCK INC., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, and STATE STREET CORP. The top five shareholders own together 37.71% of the company's share outstanding.

How many Denali Therapeutics shareholders are there?

As of Mar 2024, there are 108 institutional shareholders of Denali Therapeutics.

What percentage of Denali Therapeutics is owned by BAILLIE GIFFORD & CO?

BAILLIE GIFFORD & CO owns 14.04M shares of Denali Therapeutics, representing 10.22% of the company's total shares outstanding, valued at $288.13M (as of Mar 2024).

What percentage of Denali Therapeutics is owned by BLACKROCK INC?

As of Mar 2024, BLACKROCK INC holds 12.2M shares of Denali Therapeutics (DNLI), compromising 8.88% of the company, valued at $250.34M.

What percentage of Denali Therapeutics is owned by VANGUARD GROUP INC?

VANGUARD GROUP INC is the third largest holder of Denali Therapeutics. The company owns 10.97M of the company's shares outstanding (worth $225.07M).